Asthma self-management education for adults in primary care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with asthma in primary care will try the Walsh Asthma Self-management Programme to see if it improves daily asthma control and quality of life. The program focuses on day-to-day management and how it can be integrated by general practitioners and practice nurses. Researchers will assess how easy it is to implement the program in real-world primary care settings. The study will also determine feasibility regarding recruitment, adherence, and data collection. Results will inform future larger-scale testing in similar populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults over 18 years old
* Adults who meet one of the following criteria:

a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment.

Exclusion Criteria:

* Adults under 18 years old
* Adults with no diagnosis of asthma
* Adults receiving asthma education in a specialist hospital or community setting
* Adults unable to give informed consent
* Smoking ≥ 10 Pack Year History

Where it's running

• Royal College of Surgeons Ireland
  Dublin, D, Ireland Recruiting

Study contacts

• Study coordinator: Joanne Walsh, MSc
• Email: joannewalsh21@rcsi.com
• Phone: 01-4022300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Boosting referrals to asthma specialists after an ER visit

  This study tests whether arranging a telehealth follow-up with an asthma specialist from the ER helps adults with asthma see a specialist within 3 months more often than usual referrals.

  Recruiting University of South Florida · Tampa, Florida · NCT07396987

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• HB0056 in adults with moderate to severe asthma

  This study tests HB0056 versus a placebo to see if it helps adults with moderate to severe asthma reduce rescue inhaler use and improve symptoms.

  Recruiting at 2 sites Phase 1/2 Shanghai Huaota Biopharmaceutical Co., Ltd. · Beijing and 1 other locations · NCT07899996

• Tilrekimig (PF-07275315) for Severe Asthma: Aimed at Adults with Frequent Exacerbations

  This study tests whether tilrekimig helps people with severe asthma who have had multiple flare-ups in the past year, by comparing it to a placebo given every four weeks.

  Recruiting at 4 sites Phase 3 Pfizer · River Forest, Illinois and 11 other locations · NCT07869043

• Inhaled CHF10136 safety and pharmacokinetics in healthy adults and adults with asthma

  This first-in-human study tests inhaled CHF10136 to see if it is safe and well tolerated, how it behaves in the body, and how it affects adults with asthma compared with placebo.

  Recruiting Phase 1 Chiesi Farmaceutici S.p.A. · Leeds and 2 other locations · NCT07851623

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.